Nicole Fawcett

Director of Communications, University of Michigan Rogel Cancer

Fawcett leads a team of communicators who produce targeted, innovative communication for the Rogel Cancer Center’s research and clinical enterprises. Prior to Michigan Medicine, Fawcett was a reporter at the Detroit News and editor for a web-based community for people with disabilities.

man at table writing down in living room
Health Lab

Free online tool helps prostate cancer patients save on out-of-pocket drug costs

A free online tool could potentially save some prostate cancer patients more than $9,000 in out-of-pocket drug costs, a Michigan Medicine study finds.
glioma brain scan
Health Lab

Study finds improved survival for incurable brain tumor, providing ‘a crack in the armor’

A potential drug candidate called ONC201 nearly doubled survival for patients with diffuse midline glioma and DIPG.
money pills cancer vial yellowArtboard
Health Lab

Changing the way immune-based cancer drugs are delivered could reduce costs by 14%

An analysis finds that up to millions of dollars could be saved annually on cancer immunotherapy treatments across the Veterans Health Administration by reconsidering how those drugs are delivered.
Rogel Cancer Center illustration
News Release

Rogel Cancer Center awarded $37M from NCI

The National Cancer Institute has awarded the U-M Rogel Cancer Center a grant worth $37 million over five years and renewed the center’s designation as a “comprehensive cancer center.”
Illustrated picture of the Rogel Cancer Center building
News Release

Rogel Cancer Center awarded $37M from NCI

5-year support grant renews center’s ‘comprehensive’ status, represents 40 years of continuous funding
Signing an institutional agreement with the National Cancer Centre of Singapore (NCCS). NCCS leadership from left: Deputy Chief Executive Officer for clinical operations Lim Soon Thye; NCCS Chief Executive Officer William Hwang; and Ivy Ng, Group Chief Executive Officer for Singapore Health Services.
News Release

U-M to partner with Singapore hospital, cancer center

Institutional partnerships will foster international collaboration around research, education, cancer care and outcomes
TrEC Program members and participants 2022
News Release

Program gives undergrads a ‘pathway’ to cancer careers

A 2-week summer program offers opportunity to students beyond U-M’s Ann Arbor campus
thyroid light purple cells floating dark purple blue green faded out background
Health Lab

A ‘transformational time’ for thyroid cancer

For thyroid cancer, experts examine the current state of overdiagnosis, new therapies, health equity concerns and more.
couple looking at paper work concerned at home
Health Lab

Financial toxicity of cancer impacts partners’ quality of life

Financial toxicity of cancer impacts partners’ quality of life, with people reporting pain, fatigue and sleep issues tied to missed work and medical bills
Health Lab

Study offers clues to how cancer spreads to the brain

Michigan Medicine researchers used microfluidic devices to track what happens to cancer cells as they migrate and take root in the brain.
Cancer protein Stat5 cell yellow
Health Lab

Researchers use a new approach to hit an ‘undruggable’ target

Protein degrader shows promise against STAT5, which plays a role in leukemia and other cancers
microscope cells glioma
Health Lab

Researchers circumvent radiation resistance in subtype of brain tumors

University of Michigan Rogel Cancer Center researchers find ZMYND8 gene plays a critical role in conferring radiation resistance on brain tumors with IDH1 mutation.
microscopic colorful rainbow cells black background and yellow badge on bottom right and blue lettering saying lab notes
Health Lab

Researchers find promising new approach to stop intestinal problems caused by immune cells

New research suggests gastrointestinal diseases caused by immune system T cells could be mitigated by bolstering a common enzyme.
Doctor in room reaching out smiling
Health Lab

Treatment enhances anti-leukemia effect of bone marrow transplant, reduces recurrence, study finds

In a clinical trial, adding interferon treatment with a bone marrow transplant bolstered outcomes for patients with advanced, high-risk leukemia.
Interaction between STC1 and CRT within a cell
Health Lab

How a Little-Known Glycoprotein Blocks a Cancer Cell’s Immune Response

Targeting this inside-the-cell checkpoint could potentially improve response to cancer immunotherapy.
  • 3
  • 4
  • 5